John D. Minna
Affiliations: | Sammons Cancer Center | University of Texas Southwestern Medical Center at Dallas, Dallas, TX, United States |
Google:
"John Minna"Mean distance: (not calculated yet)
Children
Sign in to add traineeAlex Augustyn | grad student | UT Southwestern (MPROTree) | |
Sanjay Awasthi | post-doc | 1990-1991 | University of Texas Southwestern Medical Center at Dallas |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Cai L, Gao Y, DeBerardinis R, et al. (2024) A Lung Cancer Mouse Model Database. Biorxiv : the Preprint Server For Biology |
Nabet BY, Hamidi H, Lee MC, et al. (2024) Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade. Cancer Cell |
Eglenen-Polat B, Kowash RR, Huang HC, et al. (2024) A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer. Nature Communications. 15: 672 |
Kim C, Wang XD, Liu Z, et al. (2024) Induced degradation of lineage-specific oncoproteins drives the therapeutic vulnerability of small cell lung cancer to PARP inhibitors. Science Advances. 10: eadh2579 |
Chen H, Drapkin BJ, Minna JD. (2024) Proteomics: A new dimension to decode small cell lung cancer. Cell. 187: 14-16 |
Ng J, Cai L, Girard L, et al. (2024) Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. OF1-OF13 |
Sunaga N, Kaira K, Shimizu K, et al. (2023) The oncogenic role of LGR6 overexpression induced by aberrant Wnt/β-catenin signaling in lung cancer. Thoracic Cancer |
Zhu M, Kim J, Deng Q, et al. (2023) Loss of p53 and mutational heterogeneity drives immune resistance in an autochthonous mouse lung cancer model with high tumor mutational burden. Cancer Cell |
Malchers F, Nogova L, van Attekum MH, et al. (2023) Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancer. The Journal of Clinical Investigation |
Kawabe N, Matsuoka K, Komeda K, et al. (2023) Silencing of induces epithelial‑to‑mesenchymal transition in lung cancer cell lines with different effects on proliferation and clonogenic growth. Oncology Letters. 26: 391 |